Skip to content

Search

Please use this search facility to search all content found within the website:

1688 results:

Research to be excluded from anti-lobbying clause

The Department of Business, Innovation & Skills has announced its intention to exclude core research funders from the new anti-lobbying clause in government grants.Last week, Universities and…

Response to Apprenticeships inquiry

The Society responded to the Apprenticeships inquiry of House of Commons Sub-Committee on Education, Skills and the Economy. The inquiry was looking at issues such as the Government’s…

Response to Gender Pay Gap inquiry

The Women and Equalities Committee of the House of Commons conducted an inquiry to inform Government strategy on reducing the gender pay gap, focusing on women aged over 40. The…

British Pharmacological Society comments on the UN Commission on Narcotics vote on the WHO recommendation on ketamine

Professor David Webb, President of the British Pharmacological Society, comments on the UN Commission on Narcotic Drugs vote on the WHO recommendations on ketamine:“The British Pharmacological…

Lessons need to be learned from clinical trial tragedy

Lessons need to be learned from clinical trial tragedy

The recent death of a volunteer taking part in a clinical trial in France has major implications for the design of future clinical trials, says an editorial to be published in the next edition of the…

Response to United Nations Secretary-General's high-level panel on access to medicines

The United Nations Secretary-General’s High-Level Panel on Access to Medicines consulted on promoting innovation and increasing access to medicines, vaccines, diagnostics and related…

Spider toxin analogue may help relieve pain

Spider toxin analogue may help relieve pain

New research from the British Journal of Pharmacology (BJP) suggests that a compound based on a spider toxin may be effective for treating pain. Experiments conducted in rats revealed that the…

Response to EC consultation on Orphan Medicinal Products

The Society had contributed to the Royal College of Physicians' response to the European Commission consultation on orphan medicinal products via the Joint Speciality Committee for…

Response to the Big Data Dilemma inquiry

The Science and Technology Committee examined the opportunities and risks of ‘big data’ in 2015. The Society responded to the inquiry in September 2015. The Committee recently…